High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the randomized, controlled D-Lay MS trial. “Combined with data from previous studies on vitamin D as an add-on therapy, the results of the D-Lay MS trial, which show a stronger effect of […]
The post High-Dose Vitamin D Curbs Disease Activity in Early Multiple Sclerosis first appeared on News Health.
Author : News Health
Publish date : 2025-03-13 05:28:00
Copyright for syndicated content belongs to the linked Source.